Regulation of progenitor cell function by hyaluronidase

Vestnik Rossiiskoi Akademii Meditsinskikh Nauk

Volumn , Issue 11, 2009, Pages 6-9

  Dygal, A M ^a   Zyuz'Kov, G N ^a   Zhdanav, V V ^a   Vereschagin, E I ^a   Udut, E V ^a   Khrichkova, T Yu ^a   Simanina, E V ^a   Stavrova, L A ^a   Andreeva, T V ^a   Minakova, M Yu ^a   Madonov, P G ^a   Kinsht, D N ^a  

^a INSTITUTE OF PHARMACOLOGY   (Russian Federation)

Author keywords

Gyalumttc acid; Gyaluronidtue; Homing; Mobiliztion; Progenitor cells

Indexed keywords

EID: 79959225355     PISSN: 08696047     EISSN: 24143545     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. AvigdorA, Goichberg P., Shivtiel S. et al. CEVM and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ steml progenitor cells to bone marrow. Blood 2004; 103 (8): 2981-2989. (Pubitemid 38451670)
2. Noble P. W. Hyaluronan and its catabolic products in tissue injury and repair. Matrix Biol. 2002; 21: 25-29. (Pubitemid 34100819)
3. Stem R. Devising a pathway for hyaluronan catabolism: are we there yet? Glycobiology 2003; 13 (12): 105-115.
4. Nedvetdci S. Gonen E., Assayag N. et al. RHAMM, a receptor for hyaluronan-mediated motility, compensates for CD44 in inflamed CD44-knockout mice: A different inteipretation of redundancy. Proc. Natl. Acad. Sci. USA 2004: 101 (52): 18081-18086. (Pubitemid 40054077)
5. Vereschagin E. I., Khan Do-Hung et al. Radiation technology in the preparation of polyethylene oxide hydrophilic gels and immobilization of proteases for use in medical practice. Arch. Pharm. Res. 2001; 24 (3): 229-233. (Pubitemid 33703566)
6. Bonnefoix T., Bonnefoix P., Callanan M. et al. Graphical representation of a generalized linear model-based statistical test estimating the fit of the single-hit poisson model to limiting dilution assays. J. Immunol. 2001; 167 (4): 5725-5730. (Pubitemid 33062763)
7. In't Anker P. S., Noort W. A., Scherjon S. A. et al. Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar inmiunohenotype but a heterogenous multilineage differentiation potential. Haematologica 2003; 88: 845-852. (Pubitemid 37128084)
8. Henry C. B., Duling B. R. Permeation of the luminal capillary glycocalyx is determined by hyaluronan. Am. J. Phyiol. 1999; 277: 508-514.
9. Hamidi M., Azadi A., Raflei P. Pharmacokinetic consequences of pegylation. Drug Delivery 2006; 13 (7): 399-409. (Pubitemid 44470219)
10. Piedmonte D. M. Treuheit M. J. Formulation of Neulasta (per-filgrastim). Adv. Drug Delivery Rev. 2008; 60: 50-58.